InvestorsHub Logo
Followers 51
Posts 3073
Boards Moderated 1
Alias Born 06/28/2017

Re: None

Tuesday, 05/14/2019 8:57:43 AM

Tuesday, May 14, 2019 8:57:43 AM

Post# of 16650
$APHA get NICE mention in new report on the FDA CBD Trials

http://fortunenewswire.com/aurora-cannabis-acb-and-others-receive-price-upgrades-following-cbd-trial-update-research-results/

Top Cannabis companies such as Aphria (NYSE:APHA), Cronos Group (NASDAQ:CRON), Canopy Growth (NYSE:CGC) and Aurora Cannabis (NYSE:ACB) are among the most anticipated cannabis stocks to monitor during these trials, which is set to take place in April to look into how the FDA might legalize CBD-additives in food products. These four cannabis giants stand to benefit significantly from a positive out-come of the trails, which ultimately aim to loosen the constraints of adding cannabis related products to food and drinks.


Come on baby, lets break out!

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.